Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴ Oral Fluid Testing Capabilities Expanded to Identify Pertinent Drug Interactions
Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, has launched new oral fluid testing enhancements.

Aegis Sciences Corporation, a leading healthcare company that provides clinically innovative medication compliance testing and consulting services, has launched new oral fluid testing enhancements. To better support healthcare customers during the pandemic, Aegis now offers to InterACT Rx™ testing for oral fluid specimens.

InterACT Rx is a definitive, mass spectrometry test, that when used in tandem with medication compliance testing, can assist in the identification of over 200 prescription and non-prescription substances known to contribute to drug-drug interactions involving medications used in the treatment of patients with chronic pain or behavioral health conditions.

InterACT Rx gives providers a uniquely objective tool to gain critical insight into what their patients have recently ingested and potential adverse effects caused by interactions with prescribed therapy. Aegis’s “first-of-its-kind” test gives providers the only reliable way to objectively identify interactions via remote specimen collection, a critically important tool made available during the pandemic due to increased use of telehealth services.

“The disruption of healthcare services has made continuity of care challenging in the at-risk populations that our customers serve,” said Mike Ziegler, Aegis’s Chief Sales Officer. “Aegis recognized the need to make clinically essential tools available to our customers as the use of telemedicine expanded. Enhancing our remote testing offerings amidst the pandemic is a prime example of how Aegis is constantly innovating to meet the needs of our customers and the needs of their patients and clients.”

InterACT Rx testing can play a key role in medication management strategies by providing clinicians with actionable insight to prevent adverse effects from unknown sources. The reduction of inefficient treatment adjustments and follow-ups is especially vital as access to regular face-to-face assessments and treatment has been limited due to the pandemic.

“Disruptions in care caused by a reduction in ambulatory clinic visits have become common during the pandemic, and we are seeing a significant impact on providers’ abilities to effectively monitor for medication and substance use. This is also true for identification of drug interactions; our expansion of InterACT Rx testing to allow for oral fluid collection will provide clinicians with a vital tool to efficiently and objectively identify clinically important adverse interactions,” said Dr. Josh Schrecker, Director of Clinical Affairs at Aegis.

Tags : #OralFluid #AegisSciencesCorporation #InterACT #MikeZiegler #healthcareservices

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026